Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2013, Article ID 404396, 6 pages
Clinical Study

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer

Department of Radiation & Oncology, Cancer Research Center, Shohadaye-Tajrish Hospital of Shahid Beheshti University of Medical Sciences and Health Services, Tajrish Square, Tehran, Iran

Received 23 June 2013; Revised 15 August 2013; Accepted 25 August 2013

Academic Editor: Zsuzsanna Kahán

Copyright © 2013 Hamid Reza Mirzaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Hamid Reza Mirzaei, Fatemeh Nasrollahi, Ladan Mohammadi Yeganeh, Sepideh Jafari Naeini, Pegah Bikdeli, and Parastoo Hajian, “Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer,” Chemotherapy Research and Practice, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Cheng Wang, Yun-Hao Pan, Ming Shan, Ming Xu, Jia-Lin Bao, and Li-Ming Zhao, “Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel,” International Journal Of Molecular Sciences, vol. 16, no. 3, pp. 4698–4712, 2015. View at Publisher · View at Google Scholar
  • W Janni, N Harbeck, B Rack, D Augustin, J Jueckstock, A Wischnik, K Annecke, C Scholz, J Huober, T Zwingers, T W P Friedl, and M Kiechle, “Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study,” British Journal of Cancer, 2016. View at Publisher · View at Google Scholar
  • Tzu-Ching Huang, Pu-Rong Chiu, Wen-Tsan Chang, Bau-Shan Hsieh, Yu-Ci Huang, Hsiao-Ling Cheng, Li-Wen Huang, Yu-Chen Hu, and Kee-Lung Chang, “Epirubicin induces apoptosis in osteoblasts through death-receptor and mitochondrial pathways,” Apoptosis, 2018. View at Publisher · View at Google Scholar